These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 15648245)

  • 1. A folate receptor-targeted lipid nanoparticle formulation for a lipophilic paclitaxel prodrug.
    Stevens PJ; Sekido M; Lee RJ
    Pharm Res; 2004 Dec; 21(12):2153-7. PubMed ID: 15648245
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A folate receptor-targeted liposomal formulation for paclitaxel.
    Wu J; Liu Q; Lee RJ
    Int J Pharm; 2006 Jun; 316(1-2):148-53. PubMed ID: 16564654
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preparation, characterization and pharmacokinetics of folate receptor-targeted liposomes for docetaxel delivery.
    Zhai G; Wu J; Xiang G; Mao W; Yu B; Li H; Piao L; Lee LJ; Lee RJ
    J Nanosci Nanotechnol; 2009 Mar; 9(3):2155-61. PubMed ID: 19435095
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antitumor activity of folate receptor-targeted liposomal doxorubicin in a KB oral carcinoma murine xenograft model.
    Pan XQ; Wang H; Lee RJ
    Pharm Res; 2003 Mar; 20(3):417-22. PubMed ID: 12669962
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and evaluation of a novel ligand for folate-mediated targeting liposomes.
    Xiang G; Wu J; Lu Y; Liu Z; Lee RJ
    Int J Pharm; 2008 May; 356(1-2):29-36. PubMed ID: 18258394
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficient delivery of an antisense oligodeoxyribonucleotide formulated in folate receptor-targeted liposomes.
    Chiu SJ; Marcucci G; Lee RJ
    Anticancer Res; 2006; 26(2A):1049-56. PubMed ID: 16619505
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A folate receptor-targeted emulsion formulation for paclitaxel.
    Stevens PJ; Lee RJ
    Anticancer Res; 2003; 23(6C):4927-31. PubMed ID: 14981947
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Folate receptor-mediated liposomal delivery of a lipophilic boron agent to tumor cells in vitro for neutron capture therapy.
    Sudimack JJ; Adams D; Rotaru J; Shukla S; Yan J; Sekido M; Barth RF; Tjarks W; Lee RJ
    Pharm Res; 2002 Oct; 19(10):1502-8. PubMed ID: 12425468
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New Folate-Grafted Chitosan Derivative To Improve Delivery of Paclitaxel-Loaded Solid Lipid Nanoparticles for Lung Tumor Therapy by Inhalation.
    Rosière R; Van Woensel M; Gelbcke M; Mathieu V; Hecq J; Mathivet T; Vermeersch M; Van Antwerpen P; Amighi K; Wauthoz N
    Mol Pharm; 2018 Mar; 15(3):899-910. PubMed ID: 29341619
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting of pegylated liposomal mitomycin-C prodrug to the folate receptor of cancer cells: Intracellular activation and enhanced cytotoxicity.
    Patil Y; Amitay Y; Ohana P; Shmeeda H; Gabizon A
    J Control Release; 2016 Mar; 225():87-95. PubMed ID: 26809007
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficient intracellular drug and gene delivery using folate receptor-targeted pH-sensitive liposomes composed of cationic/anionic lipid combinations.
    Shi G; Guo W; Stephenson SM; Lee RJ
    J Control Release; 2002 Apr; 80(1-3):309-19. PubMed ID: 11943407
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and evaluation of a hematoporphyrin derivative in a folate receptor-targeted solid-lipid nanoparticle formulation.
    Stevens PJ; Sekido M; Lee RJ
    Anticancer Res; 2004; 24(1):161-5. PubMed ID: 15015592
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improved therapeutic activity of folate-targeted liposomal doxorubicin in folate receptor-expressing tumor models.
    Gabizon A; Tzemach D; Gorin J; Mak L; Amitay Y; Shmeeda H; Zalipsky S
    Cancer Chemother Pharmacol; 2010 May; 66(1):43-52. PubMed ID: 19779718
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intracellular uptake and intracavitary targeting of folate-conjugated liposomes in a mouse lymphoma model with up-regulated folate receptors.
    Shmeeda H; Mak L; Tzemach D; Astrahan P; Tarshish M; Gabizon A
    Mol Cancer Ther; 2006 Apr; 5(4):818-24. PubMed ID: 16648551
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel hydrolysis-resistant lipophilic folate derivative enables stable delivery of targeted liposomes in vivo.
    Huang Y; Yang T; Zhang W; Lu Y; Ye P; Yang G; Li B; Qi S; Liu Y; He X; Lee RJ; Xu C; Xiang G
    Int J Nanomedicine; 2014; 9():4581-95. PubMed ID: 25302024
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vivo antitumor activity of folate receptor-targeted liposomal daunorubicin in a murine leukemia model.
    Pan XQ; Lee RJ
    Anticancer Res; 2005; 25(1A):343-6. PubMed ID: 15816557
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vivo fate of folate-targeted polyethylene-glycol liposomes in tumor-bearing mice.
    Gabizon A; Horowitz AT; Goren D; Tzemach D; Shmeeda H; Zalipsky S
    Clin Cancer Res; 2003 Dec; 9(17):6551-9. PubMed ID: 14695160
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel pH-sensitive liposome formulation containing oleyl alcohol.
    Sudimack JJ; Guo W; Tjarks W; Lee RJ
    Biochim Biophys Acta; 2002 Aug; 1564(1):31-7. PubMed ID: 12100993
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Well-Defined Redox-Sensitive Polyethene Glycol-Paclitaxel Prodrug Conjugate for Tumor-Specific Delivery of Paclitaxel Using Octreotide for Tumor Targeting.
    Yin T; Wu Q; Wang L; Yin L; Zhou J; Huo M
    Mol Pharm; 2015 Aug; 12(8):3020-31. PubMed ID: 26086430
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comparative study of folate receptor-targeted doxorubicin delivery systems: dosing regimens and therapeutic index.
    Scomparin A; Salmaso S; Eldar-Boock A; Ben-Shushan D; Ferber S; Tiram G; Shmeeda H; Landa-Rouben N; Leor J; Caliceti P; Gabizon A; Satchi-Fainaro R
    J Control Release; 2015 Jun; 208():106-20. PubMed ID: 25869964
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.